Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

138.59
Delayed Data
As of May 26
 +2.71 / +1.99%
Today’s Change
95.14
Today|||52-Week Range
139.02
+22.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues183.6M230.3M329.5M445.3M
 
 
 
 
 
Cost of Goods Sold34.8M37.2M47.1M70.6M
 
 
 
 
 
Depreciation And Amortization2.5M2.8M3.3M--
 
 
 
 
 
Operating ExpensesGross Income146.3M190.4M279.1M374.7M
 
 
 
 
 
General Expenses131.8M160.1M213.0M284.5M
 
 
 
 
 
Research And Development30.7M35.5M48.7M66.4M
 
 
 
 
 
Total Operating Expenses169.1M200.0M263.4M355.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.6M30.3M66.2M90.1M
 
 
 
 
 
Extraordinary Charge-6.2M-1.6M-1.1M--
 
 
 
 
Other Expenses49.0K-97.0K339.0K-349.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income8.5M28.8M65.8M91.3M
 
 
 
 
 
Income Taxes-1.2M-84.9M-27.7M-39.2M
 
 
 
 
 
Net Income7.4M113.7M38.1M52.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.3M40.6M42.2M43.2M
 
 
 
 
 
Shares To Calculate EPS Diluted41.6M42.9M44.9M44.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.18$2.65$0.85$1.17
 
 
 
 
 
EPS Diluted$0.18$2.65$0.85$1.17